AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32534252 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10Hz, 3000 pulses each session)
Number of subjects: 42
Study 32534252 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 42
Study 34970882 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection of vitamin B1 into ST36 and LI4, once every other day, three times a week.
Number of subjects: 100
Study 34970882 — intervention group
Group type: COMPARATOR
Intervention: Mosapride citrate tablets (5 mg) taken orally 30 min before each of the three meals.
Number of subjects: 100
Study 35811251 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Acetazolamide 20 mg/kg/day in 3-4 divided doses for 7 days plus Corrected body (prone) position (CP+A)
Number of subjects: 72
Study 35811251 — intervention group
Group type: COMPARATOR
Intervention: Corrected body (prone) position alone (CP-A)
Number of subjects: 72
Study 33515093 — intervention group
Group type: EXPERIMENTAL
Intervention: Oily fish (300 g/week)
Number of subjects: 199
Study 33515093 — intervention group
Group type: COMPARATOR
Intervention: Poultry
Number of subjects: 199
Study 615007039 — intervention group
Group type: EXPERIMENTAL
Intervention: rhSA treatment
Number of subjects: 0
Study 615007039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36458140 — intervention group
Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri DSM 17938 probiotic recipients
Number of subjects: 72
Study 36458140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 33378520 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromelain enzyme pre-rinse
Number of subjects: 43
Study 33378520 — intervention group
Group type: COMPARATOR
Intervention: Powdered-sugar placebo pre-rinse
Number of subjects: 43
Study 32783220 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcurrent electrotherapy (EE)
Number of subjects: 53
Study 32783220 — intervention group
Group type: COMPARATOR
Intervention: Sham application (control)
Number of subjects: 53
Study 32706948 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigger Tool (TT)
Number of subjects: 201
Study 32706948 — intervention group
Group type: COMPARATOR
Intervention: Voluntary notification platform (SNEA)
Number of subjects: 201
Study 33704459 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg quinine hydrochloride (QHCl) administered intragastrically (IG)
Number of subjects: 14
Study 33704459 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg quinine hydrochloride (QHCl) administered intraduodenally (ID)
Number of subjects: 14
Study 33704459 — intervention group
Group type: COMPARATOR
Intervention: Control (no quinine) administered intragastrically (IG)
Number of subjects: 14
Study 33704459 — intervention group
Group type: COMPARATOR
Intervention: Control (no quinine) administered intraduodenally (ID)
Number of subjects: 14
Study 33704459 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg quinine hydrochloride (QHCl)
Number of subjects: 14
Study 32303242 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Stoppa approach
Number of subjects: 38
Study 32303242 — intervention group
Group type: COMPARATOR
Intervention: Ilioinguinal approach
Number of subjects: 38
Study 35227982 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to pure tone sequences
Number of subjects: 0
Study 35227982 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to complex tone sequences
Number of subjects: 0
Study 35227982 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to complex tones with odd harmonics
Number of subjects: 0
Study 35227982 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to complex tones with even harmonics
Number of subjects: 0
Study 35227982 — intervention group
Group type: COMPARATOR
Intervention: No-exposure control group
Number of subjects: 0
Study 32357579 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D tablets (1600 IU/day)
Number of subjects: 206
Study 32357579 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D oil drops (1500 IU/day)
Number of subjects: 206
Study 32357579 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D oil drops (1500 IU/day) in patients without immunoglobulin replacement
Number of subjects: 206
Study 32357579 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D tablets (1600 IU/day) in patients without immunoglobulin replacement
Number of subjects: 206
Study 33339480 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-based RCA protocol
Number of subjects: 18
Study 33339480 — intervention group
Group type: COMPARATOR
Intervention: Trial-and-error RCA protocol
Number of subjects: 18
Study 32787497 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-epibrassinolide (EBR) at 5 nM
Number of subjects: 0
Study 32787497 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-epibrassinolide (EBR) at 10 nM
Number of subjects: 0
Study 32787497 — intervention group
Group type: COMPARATOR
Intervention: Control (0 nM EBR) under waterlogging
Number of subjects: 0
Study 35568284 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised technique of IM‐MS RT
Number of subjects: 4004
Study 35568284 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-modified technique of IM‐MS RT
Number of subjects: 4004
Study 35568284 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard technique of IM‐MS RT
Number of subjects: 4004
Study 35568284 — intervention group
Group type: COMPARATOR
Intervention: No IM‐MS RT
Number of subjects: 4004
Study 35103609 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app and smart band (Mi Band 2, Xiaomi) with brief counseling
Number of subjects: 650
Study 35103609 — intervention group
Group type: COMPARATOR
Intervention: Brief counseling only
Number of subjects: 650
Study 35488356 — intervention group
Group type: EXPERIMENTAL
Intervention: Early prone position (PP) + noninvasive ventilation (NIV)
Number of subjects: 81
Study 35488356 — intervention group
Group type: COMPARATOR
Intervention: Conventional (supine) NIV
Number of subjects: 81
Study 32023661 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (FMD)
Number of subjects: 60
Study 32023661 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth ultrasonic debridement (FMUD)
Number of subjects: 60
Study 32023661 — intervention group
Group type: COMPARATOR
Intervention: Quadrant-wise scaling and root planning (Q-SRP)
Number of subjects: 60
Study 36001541 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media usage restricted to a maximum of 10 minutes per day
Number of subjects: 0
Study 36001541 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32383548 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium ascorbyl phosphate (SAP)
Number of subjects: 0
Study 32383548 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% ascorbic acid (AA)
Number of subjects: 0
Study 32383548 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 33634677 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 daily sessions per muscle group (2S)
Number of subjects: 23
Study 33634677 — intervention group
Group type: COMPARATOR
Intervention: 1 daily session per muscle group (1S)
Number of subjects: 23
Study 33225618 — intervention group
Group type: EXPERIMENTAL
Intervention: First semester %BMIp95 change
Number of subjects: 174
Study 33225618 — intervention group
Group type: EXPERIMENTAL
Intervention: Second semester %BMIp95 change
Number of subjects: 174
Study 32901113 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes mellitus (T2DM)
Number of subjects: 0
Study 32901113 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 32805434 — intervention group
Group type: EXPERIMENTAL
Intervention: LIFT mobile app‐based mindfulness intervention
Number of subjects: 152
Study 32805434 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist introduction
Number of subjects: 152
Study 32805434 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist response to symptoms
Number of subjects: 152
Study 32805434 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of intervention
Number of subjects: 152
Study 32805434 — intervention group
Group type: COMPARATOR
Intervention: Education control
Number of subjects: 152
Study 35339908 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-oriented dignity therapy
Number of subjects: 120
Study 35339908 — intervention group
Group type: COMPARATOR
Intervention: Attention (control group)
Number of subjects: 120
Study 34371972 — intervention group
Group type: COMPARATOR
Intervention: DHA-rich n-3 PUFA supplementation
Number of subjects: 0
Study 34371972 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) program
Number of subjects: 0
Study 34371972 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of DHA-rich n-3 PUFA supplementation and RT
Number of subjects: 0
Study 34371972 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 0
Study 35433468 — intervention group
Group type: COMPARATOR
Intervention: dSAPB combined with 30 ml of 0.375% ropivacaine (Group R)
Number of subjects: 80
Study 35433468 — intervention group
Group type: EXPERIMENTAL
Intervention: dSAPB combined with 30 ml of 0.375% ropivacaine plus dexmedetomidine (1 μg/kg) (Group RD)
Number of subjects: 80
Study 32070136 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG)
Number of subjects: 60
Study 32070136 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihistamine
Number of subjects: 60
Study 32070136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34094998 — intervention group
Group type: EXPERIMENTAL
Intervention: AIH group
Number of subjects: 204
Study 34094998 — intervention group
Group type: COMPARATOR
Intervention: HC group
Number of subjects: 204
Study 34094998 — intervention group
Group type: EXPERIMENTAL
Intervention: Discovery cohort (46 AIH and 92 HCs)
Number of subjects: 204
Study 34094998 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohort (22 AIH and 44 HCs)
Number of subjects: 204
Study 34094998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-regional validation cohort (12 AIH)
Number of subjects: 204
Study 33083468 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40
Study 33083468 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 36231235 — intervention group
Group type: EXPERIMENTAL
Intervention: True SAS intervention (daily self-administered acupressure on specific acupoints for seven weeks)
Number of subjects: 0
Study 36231235 — intervention group
Group type: COMPARATOR
Intervention: Placebo SAS (light acupressure on non-acupoints with the same frequency and duration as the true SAS)
Number of subjects: 0
Study 34435347 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured contraceptive counseling
Number of subjects: 658
Study 34435347 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 658
Study 34435347 — intervention group
Group type: EXPERIMENTAL
Intervention: Effectiveness chart
Number of subjects: 658
Study 34435347 — intervention group
Group type: EXPERIMENTAL
Intervention: Box of contraceptive models
Number of subjects: 658
Study 34435347 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 658
Study 32143699 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) training
Number of subjects: 140
Study 32143699 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous contact with someone with a mental health problem
Number of subjects: 140
Study 34437960 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFE bypass
Number of subjects: 172
Study 34437960 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein bypass (VBP)
Number of subjects: 172
Study 34437960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitinol stents
Number of subjects: 172
Study 34437960 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 172
Study 36495242 — intervention group
Group type: EXPERIMENTAL
Intervention: MWA + PVP
Number of subjects: 67
Study 36495242 — intervention group
Group type: COMPARATOR
Intervention: PVP
Number of subjects: 67
Study 32886200 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block (ESPB)
Number of subjects: 80
Study 32886200 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ESPB)
Number of subjects: 80
Study 32794309 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-transvenous ICD systems
Number of subjects: 0
Study 32794309 — intervention group
Group type: COMPARATOR
Intervention: Transvenous ICD systems
Number of subjects: 0
Study 35894920 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic moment of inertia bat
Number of subjects: 39
Study 35894920 — intervention group
Group type: COMPARATOR
Intervention: Weighted bat
Number of subjects: 39
Study 32867560 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma question prompt list with video intervention
Number of subjects: 359
Study 32867560 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 359
Study 32861500 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of epinephrine 0.1 μg kg-1 min-1
Number of subjects: 82
Study 32861500 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of phenylephrine 1 μg kg-1 min-1
Number of subjects: 82
Study 32861500 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of epinephrine
Number of subjects: 82
Study 32861500 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of phenylephrine
Number of subjects: 82
Study 36334724 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal seeding (n=60; infants swabbed immediately after birth using gauze preincubated in maternal vagina)
Number of subjects: 120
Study 36334724 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=60; routine standard care)
Number of subjects: 120
Study 36334724 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal seeding
Number of subjects: 120
Study 36334724 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 33875418 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted postal intervention (posted letter and leaflet)
Number of subjects: 1513
Study 33875418 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1513
Study 32208006 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient summary format (n=203)
Number of subjects: 203
Study 32208006 — intervention group
Group type: COMPARATOR
Intervention: Traditional unstructured format (n=203)
Number of subjects: 203
Study 32208006 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional unstructured + patient summary format (n=203)
Number of subjects: 203
Study 32208006 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiology colloquialisms (n=203)
Number of subjects: 203
Study 87088248 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-Focused Spouse Involvement plus Behavioral Marital Therapy (ABMT)
Number of subjects: 53
Study 87088248 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-Focused Spouse Involvement (AFSI)
Number of subjects: 53
Study 87088248 — intervention group
Group type: COMPARATOR
Intervention: Minimal Spouse Involvement (MSI)
Number of subjects: 53
Study 35996106 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted virtual reality mirror therapy (RAVRMT)
Number of subjects: 32
Study 35996106 — intervention group
Group type: COMPARATOR
Intervention: Virtual reality mirror therapy (VRMT)
Number of subjects: 32
Study 34808745 — intervention group
Group type: EXPERIMENTAL
Intervention: DRG‐PRF treatment assisted by 3D‐printed navigation template
Number of subjects: 63
Study 34808745 — intervention group
Group type: COMPARATOR
Intervention: DRG‐PRF treatment guided by conventional CT
Number of subjects: 63
Study 34808745 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 34808745 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 36198457 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (TAVNS)
Number of subjects: 88
Study 36198457 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 88
Study 33669711 — intervention group
Group type: EXPERIMENTAL
Intervention: Burden of prevention and adjustment effort to the pandemic felt by female doctors and GPs working in associated offices.
Number of subjects: 677
Study 33669711 — intervention group
Group type: EXPERIMENTAL
Intervention: Case definition quality, support received, professional life changes, and stress symptoms.
Number of subjects: 677
Study 33669711 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment measurement questionnaire.
Number of subjects: 677
Study 36250614 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour Change Wheel (BCW) intervention including pre-discharge evaluation sessions, personalised resource folder, tailored behavioural and text message support post-discharge, and a peer interaction group delivered by a trained mental health worker.
Number of subjects: 0
Study 36250614 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour Change Techniques (BCTs) such as goal setting, problem solving, feedback, social support, and information on health consequences.
Number of subjects: 0
Study 32662168 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation program (90-min sessions once a week for 9 weeks)
Number of subjects: 80
Study 35587714 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone treatment in Phenotype 1
Number of subjects: 1540
Study 35587714 — intervention group
Group type: COMPARATOR
Intervention: Phenotype 2
Number of subjects: 1540
Study 35587714 — intervention group
Group type: COMPARATOR
Intervention: Phenotype 3
Number of subjects: 1540
Study 35120498 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based learning
Number of subjects: 107
Study 35120498 — intervention group
Group type: COMPARATOR
Intervention: Group discussions
Number of subjects: 107
Study 33057792 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe punches with the fist
Number of subjects: 50
Study 33057792 — intervention group
Group type: EXPERIMENTAL
Intervention: Karate chop (small finger edge of the hand)
Number of subjects: 50
Study 33057792 — intervention group
Group type: EXPERIMENTAL
Intervention: Open hand strikes
Number of subjects: 50
Study 35755939 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 egg/day for 6 months
Number of subjects: 585
Study 34371058 — intervention group
Group type: EXPERIMENTAL
Intervention: Jedi Grip technique
Number of subjects: 92
Study 34371058 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 92
Study 34371058 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 92
Study 34540184 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine with 1 ?g/kg DEX (PRD group)
Number of subjects: 60
Study 34540184 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine (PR group)
Number of subjects: 60
Study 34540184 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine general anesthesia (G group)
Number of subjects: 60
Study 34540184 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 60
Study 35964309 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute workshop for universal suicide prevention (intervention group)
Number of subjects: 305
Study 35964309 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 305
Study 33852780 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (25 mg, two doses 3 weeks apart plus 6 weeks of daily placebo)
Number of subjects: 59
Study 33852780 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (1 mg, two doses 3 weeks apart plus 6 weeks of daily oral escitalopram)
Number of subjects: 59
Study 33852780 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 59
Study 33852780 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 59
Study 35312525 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone (SFC)
Number of subjects: 134
Study 35312525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (TIO)
Number of subjects: 134
Study 35312525 — intervention group
Group type: COMPARATOR
Intervention: High-FENO/SFC
Number of subjects: 134
Study 35312525 — intervention group
Group type: COMPARATOR
Intervention: Low-FENO/SFC
Number of subjects: 134
Study 35312525 — intervention group
Group type: COMPARATOR
Intervention: Low-FENO/TIO
Number of subjects: 134
Study 35312525 — intervention group
Group type: COMPARATOR
Intervention: High-FENO/TIO
Number of subjects: 134
Study 35074611 — intervention group
Group type: EXPERIMENTAL
Intervention: Renin-angiotensin-aldosterone system (RAAS) inhibition (losartan)
Number of subjects: 10
Study 35074611 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 10
Study 35074611 — intervention group
Group type: COMPARATOR
Intervention: Sympathoinhibition (moxonidine)
Number of subjects: 10
Study 35074611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33050917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (providers see PRO results on the same screen as the CTCAE rating)
Number of subjects: 0
Study 33050917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no access to PRO data during the CTCAE rating)
Number of subjects: 0
Study 32646295 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 0
Study 32646295 — intervention group
Group type: EXPERIMENTAL
Intervention: Journaling
Number of subjects: 0
Study 32646295 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude
Number of subjects: 0
Study 32646295 — intervention group
Group type: EXPERIMENTAL
Intervention: Outside
Number of subjects: 0
Study 32646295 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 33737313 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ACL reconstruction (index)
Number of subjects: 167
Study 33737313 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation plus optional reconstruction (comparator)
Number of subjects: 167
Study 33812837 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 94
Study 33812837 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 94